Valuation (7%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.74 | N/A |
| PEG Ratio (TTM) | -0.17 | N/A |
| P/S Ratio (TTM) | 664.40 | N/A |
| P/B Ratio (TTM) | 12.10 | N/A |
| P/FCF Ratio (TTM) | -3.90 | N/A |
| Price to 5YR AVG Earnings Ratio | -8.79 | N/A |
| Price to 5YR AVG FCF Ratio | -10.89 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -52.60% | N/A |
| ROE (TTM) | -206.69% | N/A |
| Net Profit Margin (TTM) | -16,882.37% | N/A |
| ROIC 5YR AVG | -79.78% | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -34.78% | -100.46% | -95.50% |
| Revenue | -44.49% | 28.39% | -2.88% |
| Net Income | -12.90% | -105.43% | -104.93% |
| Cash Flow | -97.20% | -18.38% | -53.79% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.74 | N/A |
| Quick Ratio (TTM) | 6.74 | N/A |
| D/E Ratio (TTM) | 2.12 | N/A |
| Interest Coverage (TTM) | -18.58 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -2.33 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.07% | N/A |